https://nl.marketscreener.com/koers/aandeel/2SEVENTY-BIO-INC-128358117/nieuws/Bristol-Myers-Squibb-en-2seventy-bio-Inc-Deel-Update-over-U-S-FDA-Oncologic-Drugs-Advisory-Commit-45888580/?utm_source=telegram&utm_medium=social&utm_campaign=share